Rethinking Inclusion & Exclusion Criteria: Should we be Dissecting Patient Heterogeneity?

Time: 3:30 pm
day: Day One

Details:

  • Interrogating Phase II clinical trial data to inform Phase III inclusion and exclusion criteria
  • How predictive algorithms may be used as part of inclusion and exclusion criteria
  • What types of therapy could be relevant to a wider patient population?

Speakers: